MX2023002182A - Analogos de ham15-52 con potencia mejorada de receptor de amilina (hamy3r). - Google Patents
Analogos de ham15-52 con potencia mejorada de receptor de amilina (hamy3r).Info
- Publication number
- MX2023002182A MX2023002182A MX2023002182A MX2023002182A MX2023002182A MX 2023002182 A MX2023002182 A MX 2023002182A MX 2023002182 A MX2023002182 A MX 2023002182A MX 2023002182 A MX2023002182 A MX 2023002182A MX 2023002182 A MX2023002182 A MX 2023002182A
- Authority
- MX
- Mexico
- Prior art keywords
- sub
- hamy3r
- ham
- analogues
- amylin receptor
- Prior art date
Links
- 108091005466 amylin receptors Proteins 0.000 title abstract 3
- ULCUCJFASIJEOE-NPECTJMMSA-N adrenomedullin Chemical group C([C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H]1C(N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)[C@@H](C)O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 ULCUCJFASIJEOE-NPECTJMMSA-N 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invención se refiere a análogos de hAM15-52 con potencia de receptor de amilina mejorada (hAMY3R) (hAMY3R-EC50 = 250 pM) y que se basan en gran medida en la secuencia del fragmento de adrenomedulina humana hAM15-52. La invención se relaciona además con análogos de hAM15-52 que son agonistas selectivos del receptor de amilina (hAMY3R) (hAMY3R-EC50 = 250 pM y un hAM1R-EC50 = 25 nM) y que se basan en gran medida en la secuencia del fragmento de adrenomedulina humana hAM15-52. Los análogos de hAM15-52 según la invención mantienen la buena estabilidad física de hAM15-52. La invención se refiere además a composiciones farmacéuticas que comprenden tales polipéptidos y su uso en el tratamiento de una condición médica tal como obesidad, NASH y/o diabetes.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20198117 | 2020-09-24 | ||
| PCT/EP2021/076250 WO2022063925A1 (en) | 2020-09-24 | 2021-09-23 | Ham15-52 analogues with improved amylin receptor (hamy3r) potency |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023002182A true MX2023002182A (es) | 2023-11-16 |
Family
ID=72659001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023002182A MX2023002182A (es) | 2020-09-24 | 2021-09-23 | Analogos de ham15-52 con potencia mejorada de receptor de amilina (hamy3r). |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20240101634A1 (es) |
| EP (1) | EP4021929B1 (es) |
| JP (1) | JP2023544959A (es) |
| KR (1) | KR20230073176A (es) |
| CN (1) | CN116322741A (es) |
| AU (1) | AU2021350396A1 (es) |
| BR (1) | BR112023002525A2 (es) |
| CA (1) | CA3189267A1 (es) |
| DK (1) | DK4021929T5 (es) |
| ES (1) | ES2950137T3 (es) |
| FI (1) | FI4021929T3 (es) |
| HR (1) | HRP20230534T1 (es) |
| HU (1) | HUE062560T2 (es) |
| IL (1) | IL300620A (es) |
| MX (1) | MX2023002182A (es) |
| PL (1) | PL4021929T3 (es) |
| PT (1) | PT4021929T (es) |
| RS (1) | RS64256B1 (es) |
| SI (1) | SI4021929T1 (es) |
| WO (1) | WO2022063925A1 (es) |
| ZA (1) | ZA202301635B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024003359A1 (en) | 2022-07-01 | 2024-01-04 | Gubra A/S | AMYLIN RECEPTOR (hAMY3R) AGONISTS WITH IMPROVED CHEMICAL STABILITY |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090286723A1 (en) | 2005-02-11 | 2009-11-19 | Amylin Pharmaceuticals, Inc. | Hybrid Polypeptides with Selectable Properties |
| US8722849B2 (en) | 2011-06-10 | 2014-05-13 | Novo Nordisk A/S | Polypeptides |
| AR097701A1 (es) * | 2013-09-19 | 2016-04-13 | Zealand Pharma As | Análogos de amilina |
| EP3271381B1 (en) | 2015-03-18 | 2021-09-08 | Zealand Pharma A/S | Amylin analogues |
| WO2019005623A1 (en) | 2017-06-30 | 2019-01-03 | Adepthera Llc | PEPTIDE ANALOGS |
| AR116632A1 (es) * | 2018-10-11 | 2021-05-26 | Intarcia Therapeutics Inc | Polipéptidos análogos de la amilina humana y sus métodos de uso |
-
2021
- 2021-09-23 KR KR1020237005061A patent/KR20230073176A/ko unknown
- 2021-09-23 MX MX2023002182A patent/MX2023002182A/es unknown
- 2021-09-23 US US18/024,879 patent/US20240101634A1/en active Pending
- 2021-09-23 FI FIEP21782735.1T patent/FI4021929T3/fi active
- 2021-09-23 IL IL300620A patent/IL300620A/en unknown
- 2021-09-23 HR HRP20230534TT patent/HRP20230534T1/hr unknown
- 2021-09-23 CA CA3189267A patent/CA3189267A1/en active Pending
- 2021-09-23 RS RS20230442A patent/RS64256B1/sr unknown
- 2021-09-23 SI SI202130047T patent/SI4021929T1/sl unknown
- 2021-09-23 EP EP21782735.1A patent/EP4021929B1/en active Active
- 2021-09-23 AU AU2021350396A patent/AU2021350396A1/en active Pending
- 2021-09-23 HU HUE21782735A patent/HUE062560T2/hu unknown
- 2021-09-23 JP JP2023510390A patent/JP2023544959A/ja active Pending
- 2021-09-23 CN CN202180056599.9A patent/CN116322741A/zh active Pending
- 2021-09-23 ES ES21782735T patent/ES2950137T3/es active Active
- 2021-09-23 PT PT217827351T patent/PT4021929T/pt unknown
- 2021-09-23 DK DK21782735.1T patent/DK4021929T5/da active
- 2021-09-23 WO PCT/EP2021/076250 patent/WO2022063925A1/en active Application Filing
- 2021-09-23 BR BR112023002525A patent/BR112023002525A2/pt unknown
- 2021-09-23 PL PL21782735.1T patent/PL4021929T3/pl unknown
-
2023
- 2023-02-09 ZA ZA2023/01635A patent/ZA202301635B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI4021929T1 (sl) | 2023-09-29 |
| WO2022063925A1 (en) | 2022-03-31 |
| AU2021350396A1 (en) | 2023-03-16 |
| RS64256B1 (sr) | 2023-07-31 |
| US20240101634A1 (en) | 2024-03-28 |
| PT4021929T (pt) | 2023-06-21 |
| JP2023544959A (ja) | 2023-10-26 |
| CA3189267A1 (en) | 2022-03-31 |
| HRP20230534T1 (hr) | 2023-08-04 |
| KR20230073176A (ko) | 2023-05-25 |
| CN116322741A (zh) | 2023-06-23 |
| FI4021929T3 (fi) | 2023-06-14 |
| DK4021929T3 (da) | 2023-07-10 |
| IL300620A (en) | 2023-04-01 |
| PL4021929T3 (pl) | 2023-07-31 |
| HUE062560T2 (hu) | 2023-11-28 |
| BR112023002525A2 (pt) | 2023-04-04 |
| ZA202301635B (en) | 2024-03-27 |
| DK4021929T5 (da) | 2024-07-29 |
| EP4021929A1 (en) | 2022-07-06 |
| EP4021929B1 (en) | 2023-04-26 |
| ES2950137T3 (es) | 2023-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP1763A (en) | Pulmonary administration of chemically modified insulin | |
| Goyal et al. | Neglected Monteggia fracture dislocations in children: a systematic review | |
| MX2020011427A (es) | Derivados del polipeptido insulinotropico dependiente de la glucosa (gip) y usos de estos. | |
| Pearl et al. | A preliminary report on micronized AlloDerm injection laryngoplasty | |
| DE69942307D1 (de) | N-terminal veränderte glp-1 abkömmlinge | |
| AR022368A1 (es) | Procedimiento para administrar peptidos insulinotropicos | |
| NO20063436L (no) | Intranasal administrasjon av glukose-regulerende peptider | |
| MX2023002182A (es) | Analogos de ham15-52 con potencia mejorada de receptor de amilina (hamy3r). | |
| DE602005023342D1 (en) | S (porcine reproductive und respiratory syndrome) von schweinen | |
| Rigby et al. | Total glossectomy without laryngectomy–a review of functional outcomes and reconstructive principles | |
| MX2009011638A (es) | Composiciones basadas en gp5 de prrsv y metodos. | |
| Magu et al. | Modified Pauwels' intertrochanteric osteotomy in neglected femoral neck fractures in children: a report of 10 cases followed for a minimum of 5 years | |
| Grinsell et al. | The functional free innervated medial gastrocnemius flap | |
| Kang et al. | Glucosamine-induced insulin resistance in ovariectomized rats is relevant to decreasing the expression of glucose transport protein subtype 4 in the skeletal muscle and in increasing the size of pancreatic islets | |
| Pearce et al. | Triplane fracture of the distal radius | |
| Aslanabadi et al. | The first description of acute compartment syndrome, by Al-Zahrawi | |
| Raphael et al. | Red blood cell transfusion and postoperative delirium in hip fracture surgery patients: a retrospective observational cohort study | |
| Haseeb et al. | Anterior abdominal wall ectopic testes: a report of two cases | |
| NO20065627L (no) | Orale produkter | |
| Singh et al. | An iatrogenic proximal radioulnar synostosis: a case report and review of literature | |
| Gaffney et al. | Deltoid compartment syndrome after antegrade humeral nailing | |
| Kumar et al. | Even After Vaccination, is the Second Wave of COVID-19 in India More Dangerous? | |
| Goswami et al. | Restless legs syndrome associated with use of stevia nonnutritive sweetener | |
| Checcucci et al. | Acute traumatic swan neck deformity: a case report of the oblique retinacular ligament lesion | |
| Baker et al. | Paper validates previous registry unicompartmental knee analyses |